NCT05961371

Brief Summary

The goal of this clinical pilot trial is to learn about the feasibility of a high-intensity resistance training intervention in peri- and early menopausal females. The main question it aims to answer are:

  • Is a 9-month resistance training intervention feasible (e.g., recruitment rates, protocol adherence, attrition) Secondary aims include examining changes in bone health, muscle strength, and menopausal symptoms. Participants will participate in a 9-month progressive, supervised, resistance training intervention. Researchers will compare secondary outcomes between the exercise group and a wait-list control group.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

December 5, 2024

Status Verified

November 1, 2024

Enrollment Period

1.3 years

First QC Date

June 26, 2023

Last Update Submit

December 3, 2024

Conditions

Keywords

ExerciseResistance TrainingStrength Training

Outcome Measures

Primary Outcomes (3)

  • Feasibility - Recruitment

    Recruitment rates - number of participants recruited per month and number of eligible participants who consented.

    Over 9 months

  • Feasibility - Adherence

    Protocol adherence (number of exercise sessions participants attend) will be expressed as a percent.

    Over 9 months

  • Feasibility - Attrition

    Attrition (number of randomized participants with valid outcome data) will be expressed as a percent.

    Over 9 months

Secondary Outcomes (19)

  • Volumetric bone mineral density (BMD)

    Baseline and 9 months

  • Bone microarchitecture

    Baseline and 9 months

  • Bone strength

    Baseline and 9 months

  • areal bone mineral density

    Baseline and 9 months

  • Muscle strength

    Baseline and 9 months

  • +14 more secondary outcomes

Study Arms (2)

Exercise

EXPERIMENTAL

In-person, supervised resistance training program

Other: Resistance Training

Control

NO INTERVENTION

Waitlist control group. Will be offered the exercise program following a 9-month wait.

Interventions

Twice weekly resistance training progressing to 5 sets of 5 repetitions of 80-90% of one repetition maximum.

Exercise

Eligibility Criteria

Age45 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old.
  • Menopause status of peri- or early menopausal: stages -2 or -1 of the stages for reproductive aging 10+ staging system or are within 5 years of their last known menses.

You may not qualify if:

  • Females who are pregnant or planning pregnancy within the next year.
  • Orthopaedic conditions that may be made worse with exercise.
  • Has low back pain, hypertension, lipidemia, diabetes, or cardiovascular disease.
  • Has a history of metabolic bone disease.
  • Has had an osteoporotic fracture within the last 5 years.
  • Had previous treatment with osteoporosis pharmacotherapy.
  • Has active glucocorticoid use.
  • Is currently participating in progressive resistance training or has in the previous 6 months.
  • Has low serum vitamin D (25(OH)D) \< 30 nmol/L or serum calcium \<2.10 mmol/L.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Calgary

Calgary, Alberta, T2N 1N4, Canada

Location

Related Publications (9)

  • Watson S, Weeks B, Weis L, Harding A, Horan S, Beck B. High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial. J Bone Miner Res. 2019 Mar;34(3):572. doi: 10.1002/jbmr.3659. Epub 2019 Feb 25. No abstract available.

    PMID: 30861219BACKGROUND
  • Kistler-Fischbacher M, Weeks BK, Beck BR. The effect of exercise intensity on bone in postmenopausal women (part 2): A meta-analysis. Bone. 2021 Feb;143:115697. doi: 10.1016/j.bone.2020.115697. Epub 2020 Dec 24.

    PMID: 33357834BACKGROUND
  • Lewis M, Bromley K, Sutton CJ, McCray G, Myers HL, Lancaster GA. Determining sample size for progression criteria for pragmatic pilot RCTs: the hypothesis test strikes back! Pilot Feasibility Stud. 2021 Feb 3;7(1):40. doi: 10.1186/s40814-021-00770-x.

    PMID: 33536076BACKGROUND
  • Finkelstein JS, Brockwell SE, Mehta V, Greendale GA, Sowers MR, Ettinger B, Lo JC, Johnston JM, Cauley JA, Danielson ME, Neer RM. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab. 2008 Mar;93(3):861-8. doi: 10.1210/jc.2007-1876. Epub 2007 Dec 26.

    PMID: 18160467BACKGROUND
  • Howe TE, Shea B, Dawson LJ, Downie F, Murray A, Ross C, Harbour RT, Caldwell LM, Creed G. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. 2011 Jul 6;2011(7):CD000333. doi: 10.1002/14651858.CD000333.pub2.

    PMID: 21735380BACKGROUND
  • Watson SL, Weeks BK, Weis LJ, Horan SA, Beck BR. Heavy resistance training is safe and improves bone, function, and stature in postmenopausal women with low to very low bone mass: novel early findings from the LIFTMOR trial. Osteoporos Int. 2015 Dec;26(12):2889-94. doi: 10.1007/s00198-015-3263-2. Epub 2015 Aug 5.

    PMID: 26243363BACKGROUND
  • Weeks BK, Beck BR. The BPAQ: a bone-specific physical activity assessment instrument. Osteoporos Int. 2008 Nov;19(11):1567-77. doi: 10.1007/s00198-008-0606-2. Epub 2008 Apr 15.

    PMID: 18414964BACKGROUND
  • Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ; STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012 Apr;97(4):1159-68. doi: 10.1210/jc.2011-3362. Epub 2012 Feb 16.

    PMID: 22344196BACKGROUND
  • Alexander CJ, Kaluta L, Whitman PW, Billington EO, Burt LA, Gabel L. Strength training for osteoporosis prevention during early menopause (STOP-EM): a pilot study protocol for a single centre randomised waitlisted control trial in Canada. BMJ Open. 2025 Feb 5;15(2):e093711. doi: 10.1136/bmjopen-2024-093711.

MeSH Terms

Conditions

Bone Diseases, MetabolicOsteoporosisMusculoskeletal DiseasesMotor Activity

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Bone DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesBehavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Leigh Gabel, PhD

    University of Calgary

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Investigators and outcome assessors will be masked to the group allocation of participants.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants will be randomized 1:1 to the exercise or waitlist control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 26, 2023

First Posted

July 27, 2023

Study Start

November 1, 2023

Primary Completion

February 1, 2025

Study Completion

June 1, 2025

Last Updated

December 5, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations